ChemicalBook >> CAS DataBase List >>Upadacitinib hemihydrate
Upadacitinib hemihydrate
- CAS No.
- 2050057-56-0
- Chemical Name:
- Upadacitinib hemihydrate
- Synonyms
- Upadacitinib hemihydrate;ABT494 hemihydrate;ABT 494 hemihydrate;ABT-494 hemihydrate;Upadacitinib Hydrate;Cinchonanium, 1-[13,5-bis(trifluoromethyllphenyllmethyl]-9-hydroxy-1'- [[3-(trifluoromethyl)phenyllmethyl},bromide(1:2), (8a,9R)-";1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, hydrate (2:1), (3S,4R)-
- CBNumber:
- CB29872273
- Molecular Formula:
- C17H21F3N6O2
- Molecular Weight:
- 398.39
- MDL Number:
- MOL File:
- 2050057-56-0.mol
Last updated:2024-01-19 13:43:48
| InChIKey | VJSRYIXHEWRBKD-NFGOAHBONA-N |
|---|---|
| SMILES | C([C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1C1=CN=C2C=NC3NC=CC=3N12)C.O |&1:1,13,r| |
| FDA UNII | NEW4DV02U5 |
Upadacitinib hemihydrate Chemical Properties,Uses,Production
Clinical Use
RINVOQ is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs). RINVOQ may be used as monotherapy or in combination with methotrexate. Each prolonged-release tablet (RINVOQ 15 mg prolonged-release tablets.) contains upadacitinib hemihydrate, equivalent to 15 mg of upadacitinib.
Upadacitinib hemihydrate Preparation Products And Raw materials
Raw materials
Preparation Products
Upadacitinib hemihydrate Suppliers
Global( 73)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| TAIZHOU YUXIN BIOTECHNOLOGY CO,.LTD | +86-576-88902229;+86-0576-88902229 +8613968687450 | yuxin@yuxchem.com | China | 158 | 58 |
| Taizhou Creating Bio-pharm co., ltd. | +8613586099526 | post@creatingbiopharm.com | China | 217 | 58 |
| CONIER CHEM AND PHARMA LIMITED | +8618523575427 | sales@conier.com | China | 49391 | 58 |
| Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471 | sales@sarms4muscle.com | China | 10523 | 58 |
| Heading （Nanjing）Pharmtechnologies Co., Ltd. | +86-25-58467899-832 +86-13382406280 | liucheng@headingpharm.com | China | 46 | 58 |
| ShenZhen Trendseen Biological Technology Co.,Ltd. | 13417589054 | trendseenbio@gmail.com | China | 11681 | 58 |
| SUZHOU SENFEIDA CHEMICAL CO.,LTD | +86-0512-83500002 +8615195660023 | sales@senfeida.com | China | 10814 | 58 |
| Jiangxi Chiyan Biopharmaceutical Technology Co.,Ltd. | +86-18616643091 +86-18616643091 | info@rochipharma.com | China | 246 | 58 |
| Zibo Hangyu Biotechnology Development Co., Ltd | +86-0533-2185556 +8617865335152 | Mandy@hangyubiotech.com | China | 11013 | 58 |
| Wuhan Jingkang en Biomedical Technology Co., Ltd | +8613720134139 | orders@jknbiochem.com | China | 4692 | 58 |
Related articles
- The synthesis method of Upadacitinib hemihydrate
- Upadacitinib, a once-daily orally administered selective JAK1 inhibitor developed by AbbVie, was approved for the treatment of....
- Jan 11，2024
View Lastest Price from Upadacitinib hemihydrate manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2022-06-25 | Upadacitinib hemihydrate
2050057-56-0
|
US $0.00 / kg | 0.1kg | 99% | 100kgs | CONIER CHEM AND PHARMA LIMITED |
-
- Upadacitinib hemihydrate
2050057-56-0
- US $0.00 / kg
- 99%
- CONIER CHEM AND PHARMA LIMITED
1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, hydrate (2:1), (3S,4R)-
Upadacitinib hemihydrate
Upadacitinib Hydrate
Cinchonanium, 1-[13,5-bis(trifluoromethyllphenyllmethyl]-9-hydroxy-1'-
[[3-(trifluoromethyl)phenyllmethyl},bromide(1:2), (8a,9R)-"
ABT 494 hemihydrate
ABT494 hemihydrate
ABT-494 hemihydrate
2050057-56-0
API